Labeler
Nuvaila Limited NDC Codes
Nuvaila Limited lists 12 finished drug products in the FDA NDC Directory under NDC labeler code 84612.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Wezlana, Amjevita, Mesalamine
- Active ingredients
- Ustekinumab, Adalimumab, Mesalamine
- NDC labeler codes
- 84612
- Strengths
- Ustekinumab 45 mg/.5mL; Ustekinumab 90 mg/mL; Adalimumab 40 mg/.4mL; Mesalamine 1.2 g/1; Ustekinumab 130 mg/26mL; Adalimumab 20 mg/.2mL; Adalimumab 80 mg/.8mL
- Dosage forms
- Injection, Solution, Injection, Tablet, Delayed release
- Routes
- Subcutaneous, Oral, Intravenous
- Drug classes (FDA established)
- Interleukin-12 Antagonist, Interleukin-23 Antagonist, Tumor Necrosis Factor Blocker, Aminosalicylate
- HCPCS / J-code
- J3357 — Injection, ustekinumab, for subcutaneous injection, 1 mg, J0135 — Injection, adalimumab, 20 mg
- Package NDCs
- 15
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Mesalamine | Mesalamine 1.2 g/1 | Tablet, Delayed releaseOral | 84612-175 | 84612-0175-13 | — |
| Wezlanaustekinumab-auub | Ustekinumab 45 mg/.5mL | Injection, SolutionSubcutaneous | 84612-055 | 84612-0055-01 | J3357 |
| Wezlanaustekinumab-auub | Ustekinumab 130 mg/26mL | Injection, SolutionIntravenous | 84612-066 | 84612-0066-01 | — |
| Wezlanaustekinumab-auub | Ustekinumab 45 mg/.5mL | Injection, SolutionSubcutaneous | 84612-076 | 84612-0076-01 | J3357 |
| Wezlanaustekinumab-auub | Ustekinumab 90 mg/mL | Injection, SolutionSubcutaneous | 84612-089 | 84612-0089-01 | J3357 |
| Amjevitaadalimumab-atto | Adalimumab 20 mg/.2mL | InjectionSubcutaneous | 84612-399 | 84612-0399-01 | J0135 |
| Amjevitaadalimumab-atto | Adalimumab 40 mg/.4mL | InjectionSubcutaneous | 84612-479 | 84612-0479-0184612-0479-02 | J0135 |
| Amjevitaadalimumab-atto | Adalimumab 80 mg/.8mL | InjectionSubcutaneous | 84612-481 | 84612-0481-0184612-0481-02 | J0135 |
| Amjevitaadalimumab-atto | Adalimumab 40 mg/.4mL | InjectionSubcutaneous | 84612-482 | 84612-0482-0184612-0482-02 | J0135 |
| Wezlanaustekinumab-auub | Ustekinumab 45 mg/.5mL | Injection, SolutionSubcutaneous | 84612-855 | 84612-0855-01 | J3357 |
| Wezlanaustekinumab-auub | Ustekinumab 45 mg/.5mL | Injection, SolutionSubcutaneous | 84612-876 | 84612-0876-01 | J3357 |
| Wezlanaustekinumab-auub | Ustekinumab 90 mg/mL | Injection, SolutionSubcutaneous | 84612-889 | 84612-0889-01 | J3357 |
Nuvaila Limited: common questions
- What is Nuvaila Limited's NDC labeler code?
- 84612. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Nuvaila Limited?
- Med-Code's HCPCS directory matches J3357, J0135 to these products. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.